title: [Clinical experience in using 18F-FDG PET in the staging and restaging of malignant lymphomas].
abstract: The present study was undertaken to determine the diagnostic accuracy of positron emission tomography (PET) in the staging and restaging of malignant lymphomas. For determination of the extent of a neoplastic process, complex radiation examination was conducted in 67 patients with malignant lymphomas. In 12 (17.9%) cases, the stage of the disease was changed, as evidenced by PET. There is evidence that the technique is of high diagnostic accuracy in detecting malignancies of l ymph nodes, skeletal system, and parenchymatous organs in lymphoproliferative diseases.
authors.forename: M S
authors.initials: MS
authors.lastname: Tlostanova
authors.forename: L A
authors.initials: LA
authors.lastname: Tiutin
authors.forename: D V
authors.initials: DV
authors.lastname: Ryzhkova
authors.forename: N V
authors.initials: NV
authors.lastname: Il'in
authors.forename: E I
authors.initials: EI
authors.lastname: Ivanova
authors.forename: Iu N
authors.initials: IuN
authors.lastname: Vinogradova
authors.forename: A A
authors.initials: AA
authors.lastname: Ivanova
authors.forename: O N
authors.initials: ON
authors.lastname: Savchenko
mesh_terms: D003627:Data Interpretation, Statistical; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008223:Lymphoma / Q000000981:diagnostic imaging / Q000473:pathology; D008297:Male; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18